13 May, 2026 | Wednesday | News

Next-generation anti-CD19 CAR-T, Anbal-cel (CRC01), approval highlights Korean innovation Given the accelerating global momentum in CAR-T and gene therapies, ProBio Inc. and Curocell have achieved a signi...

14 May, 2026 | Thursday | News

Isomorphic Labs will use the funding to power its world-leading AI drug design engine, scale its business globally and progress its drug candidate pipeline. Isomorphic Labs, an AI-first drug design and develop...

20 May, 2026 | Wednesday | News

Agilent Technologies Inc.  announced a two-year research  collaboration agreement with Singapore’s Nucleic Acid Therapeutics Initiative (NATi), hosted by Agency  for Science, Technology and...

19 May, 2026 | Tuesday | News

LOTTE Biologics (Co-CEOs James Park and Yooyeol Shin) announce an expansion of its collaboration with Ottimo Pharma, an innovative biotech company developing one-of-a-kind PD-1/VEGFR2 dual-paratopic antibo...

18 May, 2026 | Monday | News

Singapore Post Limited ("SingPost") and Fullerton Healthcare Group Private Limited ("Fullerton Health") have announced the signing of a Memorandum of Understanding ("MOU") to explore the co-development of a rob...

20 May, 2026 | Wednesday | News

Strategic Initiative Strengthens Berlin as Europe's Hub of Digital Cardiology BIOTRONIK, die Charité – Universitätsmedizin Berlin, and the German Heart Center Foundation announced a research ...

21 May, 2026 | Thursday | News

Phase 1 KOALA clinical trial evaluating KMCAR™ T-cell therapy in relapsed/refractory kappa-restricted multiple myeloma now open for patient enrolment The KOALA study, underway at Peter Mac’s Cent...